10-Q Filing

ROCKET LAB CORP CIK: 1819994 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001213900-20-037159`
Period End Date	20200930
Filing Date	20201116
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	vacq-20200930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 21 Income Statement 2 Cash Flow Statement 21 Stockholders Equity 9

Balance Sheet 21 line items

Line Item	Tag	Value	Unit	Period
Preferred shares, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$924.37K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Preferred shares, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Prepaid expense	`PrepaidExpenseCurrent`	$428.15K	USD	Point-in-time
Preferred shares, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$1.35M	USD	Point-in-time
Cash held in Trust Account	`AssetsHeldInTrustNoncurrent`	$300.00M	USD	Point-in-time
Preferred shares, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
TOTAL ASSETS	`Assets`	$301.35M	USD	Point-in-time
Current liability - accrued expenses	`AccruedLiabilitiesCurrent`	$600.00	USD	Point-in-time
Deferred underwriting fee payable	`DeferredUnderwritingFeesPayable`	$10.50M	USD	Point-in-time
Total Liabilities	`Liabilities`	$10.50M	USD	Point-in-time
Commitments and Contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Class A ordinary shares subject to possible redemption, 28,585,191 shares at $10.00 per share	`TemporaryEquityCarryingAmountAttributableToParent`	$285.85M	USD	Point-in-time
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$5.02M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-20.70K	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$5.00M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	-	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$301.35M	USD	Point-in-time

Income Statement 2 line items

Line Item	Tag	Value	Unit	Period
Operating and formation costs	`OperatingCostsAndExpenses`	$20.70K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-20.70K	USD	1 Quarter

Cash Flow Statement 21 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-20.70K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$428.15K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$600.00	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-448.25K	USD	1 Quarter
Investment of cash in Trust Account	`PaymentsToAcquireInvestments`	$300.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-300.00M	USD	1 Quarter
Proceeds from sale of Units, net of underwriting discounts paid	`ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid`	$294.00M	USD	1 Quarter
Proceeds from sale of Private Placement Warrants	`ProceedsFromIssuanceOfPrivatePlacement`	$8.00M	USD	1 Quarter
Proceeds from promissory note related party	`ProceedsFromRelatedPartyDebt`	$300.00K	USD	1 Quarter
Repayment of promissory note related party	`RepaymentsOfRelatedPartyDebt`	$300.00K	USD	1 Quarter
Payments of offering costs	`PaymentsOfStockIssuanceCosts`	$627.38K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$301.37M	USD	1 Quarter
Net Change in Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$924.37K	USD	1 Quarter
Cash Beginning	`CashAndCashEquivalentsAtCarryingValue`	$924.37K	USD	Point-in-time
Cash Beginning	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash Ending	`CashAndCashEquivalentsAtCarryingValue`	$924.37K	USD	Point-in-time
Cash Ending	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Initial classification of ordinary shares subject to possible redemption	`InitialClassificationOfOrdinarySharesSubjectToPossibleRedemption`	$285.85M	USD	1 Quarter
Change in value of ordinary shares subject to possible redemption	`ChangeInValueOfOrdinarySharesSubjectToPossibleRedemption`	$-1.85K	USD	1 Quarter
Deferred underwriting fee payable	`DeferredUnderwritingFeePayable`	$10.50M	USD	1 Quarter
Deferred offering costs paid directly by Sponsor from proceeds of issuance of Class B ordinary shares	`DeferredOfferingCostsPaidDirectlyBySponsorFromProceedsOfIssuanceOfClassBOrdinaryShares`	$25.00K	USD	1 Quarter

Stockholders Equity 9 line items

Line Item	Tag	Value	Unit	Period
Balance at Beginning	`StockholdersEquity`	$5.00M	USD	Point-in-time
Balance at Beginning	`StockholdersEquity`	-	USD	Point-in-time
Issuance of Class B ordinary shares to Sponsor	`StockIssuedDuringPeriodValueNewIssues`	$25.00K	USD	1 Quarter
Sale of 30,000,000 Units, net of underwriting discounts and offering costs	`SaleOfNetOfUnderwritingDiscountsAndOfferingCosts`	$282.85M	USD	1 Quarter
Sale of 5,333,333 Private Placement Warrants	`SaleOfPrivatePlacementWarrants`	$8.00M	USD	1 Quarter
Ordinary shares subject to possible redemption	`StockRedeemedOrCalledDuringPeriodValue`	$-285.85M	USD	1 Quarter
Net loss	`ProfitLoss`	$-20.70K	USD	1 Quarter
Balance Ending	`StockholdersEquity`	$5.00M	USD	Point-in-time
Balance Ending	`StockholdersEquity`	-	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.